| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9be712d6dbdaa4c2dd1981caeae59ed4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 |
| filingDate |
1998-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db7f5b633eecbf56964d5bf4c7b7476 |
| publicationDate |
2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-19856668-A1 |
| titleOfInvention |
Active substance matrix in the form of a bioabsorbable porous nonwoven, process for its preparation and use |
| abstract |
The invention relates to a drug matrix in the form of a bioabsorbable porous nonwoven fabric of collagen fibrils in lyophilized form with a sustained release of active ingredients. The matrix contains at least one in water and body fluids sparingly soluble active ingredient in a homogeneous distribution. For their preparation, a sparingly soluble active substance in finely divided form is added to a collagen suspension prepared in a specific manner. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10517836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10318991-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011272839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012003350-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102970987-A |
| priorityDate |
1998-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |